MarketPeel
Insider Trading Intelligence
Pricing
…
IL

Innoviva Strategic Opportunities Llc

ARMP
DIRECTOR · ARMATA PHARMACEUTICALS, INC. · CIK 0001842875
FILING MIX · LIFETIME100%/0%
BUYS
10
SELLS
0
TOTAL VALUE
$98.04M
COMPANIES
1
ACTIVE SINCE
Jan 2021
HOLDINGS NOW
2,692,604
AVG SELL PX
—
TRADE KIND
SHOWING 10 / 10
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
10 backtested trades · 8 horizonsHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Innoviva Strategic Opportunities Llc, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d10+80.00%+15.31%-0.76%+16.07%+4.56%—
14d10+80.00%+19.39%-1.39%+20.79%+9.02%—
30d10+40.00%+9.33%-1.85%+11.18%+3.15%—
60d10+60.00%+4.78%-0.43%+5.22%+4.14%—
90d10+30.00%-5.40%-2.36%-3.04%-9.24%—
180d10+30.00%-10.57%+0.67%-11.23%-8.58%—
1y10+30.00%-6.45%+2.89%-9.35%-30.66%—
2y10+10.00%-24.20%+13.37%-37.57%-35.81%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
ARMP · 2,692,604 shares · as of Mar 31, 2022
04,091,4928,182,98512,274,47716,365,9692022SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2021
2021
2021
2021
2022
2022
2022
2022
2023
FLOW · 10 buys / 0 sellsCOVERAGE · 9 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
ARMP
ARMATA PHARMACEUTICALS, INC.
PURCHASE
—$30,000,000.00——Jan 10, 2023Jan 12, 2023 ↗View →
ARMP
ARMATA PHARMACEUTICALS, INC.
PURCHASE
5,385,208$5.00$26.93M16,365,969Mar 31, 2022Apr 1, 2022 ↗View →
ARMP
ARMATA PHARMACEUTICALS, INC.
PURCHASE
0$5.00—2,692,604Mar 31, 2022Apr 1, 2022 ↗View →
ARMP
ARMATA PHARMACEUTICALS, INC.
PURCHASE
1,807,396$5.00$9.04M1,807,396Feb 9, 2022Feb 11, 2022 ↗View →
ARMP
ARMATA PHARMACEUTICALS, INC.
PURCHASE
3,614,792$5.00$18.07M10,980,761Feb 9, 2022Feb 11, 2022 ↗View →
ARMP
ARMATA PHARMACEUTICALS, INC.
PURCHASE
1,212,122$3.30$4.00M7,365,969Oct 29, 2021Nov 1, 2021 ↗View →
ARMP
ARMATA PHARMACEUTICALS, INC.
PURCHASE
4,285,935$3.25$13.93M6,153,847Mar 17, 2021Mar 17, 2021 ↗View →
ARMP
ARMATA PHARMACEUTICALS, INC.
PURCHASE
4,285,935$3.25$13.93M6,153,847Mar 17, 2021Mar 17, 2021 ↗View →
ARMP
ARMATA PHARMACEUTICALS, INC.
PURCHASE
1,867,912$3.25$6.07M1,867,912Jan 26, 2021Jan 28, 2021 ↗View →
ARMP
ARMATA PHARMACEUTICALS, INC.
PURCHASE
1,867,912$3.25$6.07M1,867,912Jan 26, 2021Jan 28, 2021 ↗View →
Other insiders · ARMP
Loading peer insiders…
About this filer
CIK 0001842875
ROLE
Director
PRIMARY
ARMP
COMPANIES
1
ACTIVE SINCE
Jan 2021
MARKETPEEL · /INSIDER/0001842875DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback